<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcell.2016.00121</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Hypothesis and Theory</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Origin of Cancer: An Information, Energy, and Matter Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hanselmann</surname> <given-names>Rainer G.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/309424/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Welter</surname> <given-names>Cornelius</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/313256/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Human Genetics, Saarland University</institution> <country>Homburg, Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Beratungszentrum f&#x000FC;r Hygiene</institution> <country>Freiburg, Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Roland Wohlgemuth, Sigma-Aldrich Chemie GmbH, Switzerland</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Christian Frezza, Hutchison/MRC Research Institute, UK; Thomas N. Seyfried, Boston College, USA</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Rainer G. Hanselmann <email>dr.hanselmann&#x00040;mac.com</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Molecular Medicine, a section of the journal Frontiers in Cell and Developmental Biology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>4</volume>
<elocation-id>121</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>07</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016 Hanselmann and Welter.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Hanselmann and Welter</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Cells are open, highly ordered systems that are far away from equilibrium. For this reason, the first function of any cell is to prevent the permanent threat of disintegration that is described by thermodynamic laws and to preserve highly ordered cell characteristics such as structures, the cell cycle, or metabolism. In this context, three basic categories play a central role: energy, information, and matter. Each of these three categories is equally important to the cell and they are reciprocally dependent. We therefore suggest that energy loss (e.g., through impaired mitochondria) or disturbance of information (e.g., through mutations or aneuploidy) or changes in the composition or distribution of matter (e.g., through micro-environmental changes or toxic agents) can irreversibly disturb molecular mechanisms, leading to increased local entropy of cellular functions and structures. In terms of physics, changes to these normally highly ordered reaction probabilities lead to a state that is irreversibly biologically imbalanced, but that is thermodynamically more stable. This primary change&#x02014;independent of the initiator&#x02014;now provokes and drives a complex interplay between the availability of energy, the composition, and distribution of matter and increasing information disturbance that is dependent upon reactions that try to overcome or stabilize this intracellular, irreversible disorder described by entropy. Because a return to the original ordered state is not possible for thermodynamic reasons, the cells either die or else they persist in a metastable state. In the latter case, they enter into a self-driven adaptive and evolutionary process that generates a progression of disordered cells and that results in a broad spectrum of progeny with different characteristics. Possibly, 1 day, one of these cells will show an autonomous and aggressive behavior&#x02014;it will be a cancer cell.</p></abstract>
<kwd-group>
<kwd>entropy</kwd>
<kwd>cancer</kwd>
<kwd>carcinogenesis</kwd>
<kwd>warburg effect</kwd>
<kwd>mutations</kwd>
<kwd>aneuploidy</kwd>
<kwd>microenvironment</kwd>
<kwd>matter</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="99"/>
<page-count count="12"/>
<word-count count="9793"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Since 1858, when Rudolf Virchow formulated the idea that cancer cells are the body&#x00027;s own cells (Virchow, <xref ref-type="bibr" rid="B90">1858</xref>), many hypotheses have been proposed to explain the origin of cancer cells and how they develop such a heterogenetic morphology, increased proliferation, metastatic capacity, and invasive behavior.</p>
<p>Several theories have been formulated, but even the most prominent and accepted model (mutation theory) are confronted by a growing amount of experimental data and arguments that could either not explained by the model, or that contradicted this model. For example, Mack et al studied subtypes of three ependymoma brain tumors and found that one subtype carries an intrachromosomal translocation that creates a new tumor-driving gene, another lacks tumor-driving mutations but has aberrant epigenetic modifications, and a third shows neither gene mutations nor epigenetic aberrations (Mack et al., <xref ref-type="bibr" rid="B55">2014</xref>; Versteeg, <xref ref-type="bibr" rid="B89">2014</xref>). On the other hand, Martincorena and colleagues found thousands of mutations in cancer-relevant genes, including cancer-driver genes, in normal eyelid epidermis that rarely develop cancers (Martincorena et al., <xref ref-type="bibr" rid="B57">2015</xref>). This finding stands in contrast to the mutation hypothesis because, if mutations really are the exclusive cause of cancer, then how can the hypothesis explain, on the one hand, the existence of cancers <italic>without mutations</italic>, and on the other, the fact that <italic>normal</italic> tissues can display massive genetic changes including changes in cancer-initiating and cancer-driving genes? Furthermore, during recent decades, in several transfer experiments (nucleus and mitochondrial transfer) the tumor-suppressing effect of normal cytoplasm, as well as of normal mitochondria, could be demonstrated, despite the presence of cancerous nuclear genomes (Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>). For example, Kaipparettu et al. (<xref ref-type="bibr" rid="B41">2013</xref>) were able to show that the introduction of non-cancerous mitochondria into highly malignant breast cancer cells could reverse malignancy and down-regulate several oncogenic pathways such as invasion, <italic>in vivo</italic> tumor growth, and others. Moreover, there are several non-genotoxic (non-mutagenic) carcinogens including chloroform and <italic>p</italic>-dichlorobenzene that provoke cancer formation (Mally and Chipman, <xref ref-type="bibr" rid="B56">2002</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>; Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>). However, we saw in the last decade the renaissance of old (Hansemann, <xref ref-type="bibr" rid="B35">1892</xref>; Boveri, <xref ref-type="bibr" rid="B11">1914</xref>; Duesberg, <xref ref-type="bibr" rid="B18">2005</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>; Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>) and the formulation of new hypotheses (Baker, <xref ref-type="bibr" rid="B5">2015</xref>; Tomasetti and Vogelstein, <xref ref-type="bibr" rid="B81">2015</xref>) that have all failed to show that they are the exclusive initiator and origin of cancer. For example, Warburg (<xref ref-type="bibr" rid="B93">1956</xref>) suggested that the disturbance of oxidative phosphorylation which results in cellular energy loss has a high impact on cancer formation, though this concept cannot explain the fact that hereditary mitochondrial diseases are not associated with an increased rate of cancer formation, even when most mitochondria are affected (Moggia et al., <xref ref-type="bibr" rid="B64">2014</xref>). On the other hand, in recent years, several studies have shown a causal link between oncogenic genes, and the disturbance of mitochondria. For example, Matoba et al. (<xref ref-type="bibr" rid="B59">2006</xref>) observed that p53<sup>&#x02212;/&#x02212;</sup> mice exhibit impaired mitochondrial respiration, and Bensaad et al. (<xref ref-type="bibr" rid="B9">2006</xref>) identified a novel p53-inducible regulator of glycolysis. Actually, there is a controversial debate as to whether mutated cancer-relevant genes or disturbed mitochondria are the initial cause of cancer formation. In that discussion, we have to take into account that, besides mitochondria, mutated oncogenes such as that encoding E2F transcription factor (Benevolenskaya and Frolov, <xref ref-type="bibr" rid="B8">2015</xref>) or p53 (Kamp et al., <xref ref-type="bibr" rid="B43">2016</xref>) simultaneously affect other cellular mechanisms such as DNA repair and mitosis (Vitale et al., <xref ref-type="bibr" rid="B91">2010</xref>). For that reason, it will be difficult to decide which is the primary cause and whether either is responsible exclusively for cancer initiation.</p>
<p>At the beginning of the last century, another popular hypothesis was published concerning the origin of cancer. It was formulated by Theodore Boveri, a German biologist (Boveri, <xref ref-type="bibr" rid="B11">1914</xref>). Based on his own experiments with sea urchin eggs and the works of (Hansemann, <xref ref-type="bibr" rid="B35">1892</xref>), he formulated a comprehensive monograph about the origin and possible causes that he supposed would lead to chromosomal imbalance in post-mitotic daughter cells (aneuploidy) and finally to cancer. Whereas, Boveri principally assumed that single mitotic errors can lead to cancer cells, most scientists today believe that once aneuploid cells occur, a process of chromosomal instability (CIN) becomes initiated, which is the basis for cancer cell formation through an evolutionary process. This model implies that aneuploidy itself destabilizes karyotypes automatically and impels progression toward CIN and cancer (Duesberg, <xref ref-type="bibr" rid="B19">2014</xref>) on its own terms.</p>
<p>Today, it is clear that aneuploidy is a common genetic feature of solid tumors (Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>). Whether mutation in cancer-related genes (Holland and Cleveland, <xref ref-type="bibr" rid="B38">2009</xref>; Thompson et al., <xref ref-type="bibr" rid="B80">2010</xref>; Holland and Cleveland, <xref ref-type="bibr" rid="B39">2012</xref>), or accidental appearance of chromosome mis-segregation during mitosis (Thompson et al., <xref ref-type="bibr" rid="B80">2010</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>), or by tetraploid progenitor cells (Ganem et al., <xref ref-type="bibr" rid="B26">2007</xref>; Storchova and Kuffer, <xref ref-type="bibr" rid="B75">2008</xref>), or because of epigenetic mechanisms (Herrera et al., <xref ref-type="bibr" rid="B37">2008</xref>), or centrosome aberrations (Nigg, <xref ref-type="bibr" rid="B66">2002</xref>) or other possible causes is under intensive investigation and discussion. However, there is some evidence indicating that aneuploidy cannot be the only reason for carcinogenesis. For example, Weaver and Cleveland and others found that aneuploidy suppresses rather than promotes tumorgenesis (Weaver and Cleveland, <xref ref-type="bibr" rid="B94">2007</xref>; Weaver et al., <xref ref-type="bibr" rid="B95">2007</xref>; Torres et al., <xref ref-type="bibr" rid="B82">2008</xref>), but if aneuploidy is so deleterious, why, then, are most solid tumors aneuploid? Furthermore, individuals with Down syndrome carrying an extra copy of chromosome 21 have a 50% lower risk of developing a solid tumor but a significantly higher risk of developing leukemia, as compared to individuals with a normal karyogram (Hasle et al., <xref ref-type="bibr" rid="B36">2000</xref>). On the other hand, aneuploidy is an early event found in typical pre-cancer stages such as cervix dysplasia, Barrett esophagus, leukoplakia and bronchus dysplasia (Sandritter, <xref ref-type="bibr" rid="B73">1965</xref>; Reid et al., <xref ref-type="bibr" rid="B71">2000</xref>; Hanselmann and Oberringer, <xref ref-type="bibr" rid="B34">2001</xref>; Lothsch&#x000FC;tz et al., <xref ref-type="bibr" rid="B54">2002</xref>; van Zyl et al., <xref ref-type="bibr" rid="B88">2012</xref>) liver cirrhosis (Attallaha et al., <xref ref-type="bibr" rid="B2">1999</xref>) and others (Bohm and Sandritter, <xref ref-type="bibr" rid="B10">1975</xref>). It is interesting that aneuploidy is even detectable in chronic inflammatory tissue such as wounds (Ermis et al., <xref ref-type="bibr" rid="B21">1998</xref>; Oberringer et al., <xref ref-type="bibr" rid="B68">1999</xref>) and inflammatory bronchial tissue (Hanselmann and Oberringer, <xref ref-type="bibr" rid="B34">2001</xref>; Lothsch&#x000FC;tz et al., <xref ref-type="bibr" rid="B54">2002</xref>), after acute and chronic hypoxic conditions (Ueyama et al., <xref ref-type="bibr" rid="B85">2012</xref>; Kondoh et al., <xref ref-type="bibr" rid="B50">2013</xref>), and after exposure to physical (Grosovsky et al., <xref ref-type="bibr" rid="B32">1996</xref>; Kirsch-Volders et al., <xref ref-type="bibr" rid="B47">1996</xref>) or chemical stressors (Galloway and Ivett, <xref ref-type="bibr" rid="B25">1986</xref>; Mattiuzzo et al., <xref ref-type="bibr" rid="B60">2006</xref>; Tayama et al., <xref ref-type="bibr" rid="B79">2008</xref>). However, there are many pros and cons in the context of aneuploidy as a reason for cancer development, but as Yuen and Desai assume, the persistence of aneuploid cells in tumors requires not only chromosome mis-segregation but also additional, as yet poorly defined, events (Yuen and Desai, <xref ref-type="bibr" rid="B99">2008</xref>).</p>
<p>In summary, at the time of writing, there is no experiment that proves that any of the hypotheses that have been propounded represents the exclusive cause of cancer. For further arguments, please see Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Pros and cons of different theories and hypotheses indicate that no one theory can claim to be the exclusive cause of cancer initiation and progression</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Theory, hypothesis</bold></th>
<th valign="top" align="left"><bold>Pros</bold></th>
<th valign="top" align="left"><bold>Cons</bold></th>
</tr>
</thead>
<tbody>
<tr style="border-bottom: thin solid #000000;">
<td valign="top" align="left">Mutation theory</td>
<td valign="top" align="left">Mutations are detectable in most cancers (Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>).<break/>Hereditary cancer diseases (Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>). Induction of cancer by targeted mutation of cancer genes in animals (Ko et al., <xref ref-type="bibr" rid="B49">2004</xref>).<break/>Mutations can induce aneuploidy and CIN (Lengauer et al., <xref ref-type="bibr" rid="B52">1998</xref>).</td>
<td valign="top" align="left">Normal tissue shows high incidence of mutations even in cancer-driver genes (Martincorena et al., <xref ref-type="bibr" rid="B57">2015</xref>).<break/>Physiological mutation rate cannot explain cancer development (Duesberg, <xref ref-type="bibr" rid="B18">2005</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>).<break/>Identification of cancer disease without cancer-relevant mutations (Mack et al., <xref ref-type="bibr" rid="B55">2014</xref>; Versteeg (<xref ref-type="bibr" rid="B89">2014</xref>).<break/> Mutations cannot explain the pathogenetic causality of early mutation appearance and years of latency of cancer development (Duesberg, <xref ref-type="bibr" rid="B18">2005</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>).<break/> Cannot explain mitochondrial and nucleus transfer experiments (see: Introduction, Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>).</td></tr>
<tr style="border-bottom: thin solid #000000;">
<td valign="top" align="left">Chromosomal imbalance, Speciation theory, Aneuploidy and CIN</td>
<td valign="top" align="left">Aneuploidy is detectable in most tumors (Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>).<break/>Aneuploidy is detectable in pre-cancer stages [Barrett esophagus (Reid et al., <xref ref-type="bibr" rid="B71">2000</xref>), chronic infection (Attallaha et al., <xref ref-type="bibr" rid="B2">1999</xref>); chronic inflammation (Lothsch&#x000FC;tz et al., <xref ref-type="bibr" rid="B54">2002</xref>)].</td>
<td valign="top" align="left">Not every cell within a tumor shows chromosomal aberrations (Lengauer et al., <xref ref-type="bibr" rid="B52">1998</xref>).<break/>Constitutional aneuploidy in the normal human brain (Rehen et al., <xref ref-type="bibr" rid="B70">2005</xref>).<break/>Cannot explain mitochondrial and nucleus transfer experiments (see: Introduction, Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>).</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td valign="top" align="left">Mitochondrial dysfunction, Energy loss (Warburg effect)</td>
<td valign="top" align="left">Detectable in all tumors (Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>).<break/>Induction of cancer by transfer of dysfunctional mitochondria (Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>).<break/>Induction of cancer by mitochondrial toxic agents (Warburg, <xref ref-type="bibr" rid="B93">1956</xref>).</td>
<td valign="top" align="left">Mitochondrial dysfunctions are not the initial step in hereditary cancer development (see introduction).<break/>No hereditary mitochondropathies show an increased cancer rate (Moggia et al., <xref ref-type="bibr" rid="B64">2014</xref>).<break/>The hypothesis cannot explain the development of cancer by many substances that directly disrupt mitotic spindle aperture and induce aneuploidy and CIN (Duesberg, <xref ref-type="bibr" rid="B18">2005</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Environment and matter</td>
<td valign="top" align="left">Micro-environmental changes can induce cancer (Gatenby and Gillies, <xref ref-type="bibr" rid="B29">2008</xref>; Baker, <xref ref-type="bibr" rid="B5">2015</xref>) such as hormones (Tsutsui and Barrett, <xref ref-type="bibr" rid="B83">1997</xref>), low pH (Takeshi, <xref ref-type="bibr" rid="B77">1995</xref>).</td>
<td valign="top" align="left">Micro-environmental changes are not the first step in the development of hereditary cancers, because inherited mutations are the initiator of that process (Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>; Tomasetti and Vogelstein, <xref ref-type="bibr" rid="B81">2015</xref>).</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Furthermore, when we are looking at a broad range of hypotheses that show, experimentally, a varying degree of impact on cancer initiation and progression, it is difficult to believe that any single model can lay claim to explaining the cause and progression of cancer diseases exclusively. To overcome the dilemmas of correct-in-principle, but competing models, the establishment of an overarching framework that combines these different models is reasonable. In order to establish such a framework, it makes sense to identify the higher principles that lie behind each individual cancer model, creating the opportunity to place them within a small number of basic categories and to bring them into the context of one of the most fundamental laws of nature&#x02014;thermodynamics.</p>
</sec>
<sec id="s2">
<title>Basic principles of life</title>
<p>For more than 2000 years, humans have tried to define the basic principles of the universe (Umpleby, <xref ref-type="bibr" rid="B86">2007</xref>), leading us to fundamental theories such as quantum mechanics and Albert Einstein&#x00027;s general theory of relativity. Based on those fundamental theories, general systems theorists emphasized that matter, energy and information are basic categories in our universe that are linked at the quantum level, and for that reason, some assume that they must be fundamental for life too (Miller, <xref ref-type="bibr" rid="B63">1978</xref>; Umpleby, <xref ref-type="bibr" rid="B86">2007</xref>).</p>
<p>A cell is the fundamental unit of life: capable of self-preservation by self-organization and autonomous reproduction (Karsenti, <xref ref-type="bibr" rid="B44">2008</xref>; Davies et al., <xref ref-type="bibr" rid="B17">2013</xref>). In recent decades, it has become clear that a cell is a thermodynamically open system (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>) that is far from thermodynamic equilibrium, and it is generally accepted that such systems need a permanent supply of energy for self-preservation (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>; Molnar et al., <xref ref-type="bibr" rid="B65">2011</xref>; Davies et al., <xref ref-type="bibr" rid="B17">2013</xref>; Gatenby and Frieden, <xref ref-type="bibr" rid="B28">2013</xref>; Tarabichi et al., <xref ref-type="bibr" rid="B78">2013</xref>). For that reason, cells permanently ingest fuels (e.g., glucose, oxygen) and generate energy-bearing molecules (e.g., ATP, GTP) mainly by respiration (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>). Energy is vital for the cell and it is involved in all molecular biological and biochemical processes. This dependency becomes obvious when cells completely disintegrate structurally and metabolically after they have lost too much energy (cell death &#x0003D; entropy). But to preserve the steady state of order, the cell must ingest nutrition (matter) such as amino acids, lipids, carbohydrates or electrolytes from the surrounding environment (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>). Under physiological conditions, the cell&#x00027;s surroundings are perfectly adjusted to the cell&#x00027;s needs, but what happens when the environment changes significantly or the nutrition supply becomes disturbed? In the past, many environmental changes such as hypoxia, chronic inflammation, irradiation and hormones have demonstrated that they can induce or support cancer cell formation (Gatenby and Gillies, <xref ref-type="bibr" rid="B29">2008</xref>; Rademakers et al., <xref ref-type="bibr" rid="B69">2008</xref>; Tayama et al., <xref ref-type="bibr" rid="B79">2008</xref>; Castello et al., <xref ref-type="bibr" rid="B15">2010</xref>; Nishisgori, <xref ref-type="bibr" rid="B67">2015</xref>; Michiels et al., <xref ref-type="bibr" rid="B62">2016</xref>), and from studies of cancers it is well known that they are surrounded by massive environmental changes (Gatenby and Gillies, <xref ref-type="bibr" rid="B29">2008</xref>; Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>; Gillies and Gatenby, <xref ref-type="bibr" rid="B30">2015</xref>). These findings clearly indicate that environmental (matter) changes have a great impact on cancer development. However, without genetic information, neither the construction nor the preservation of life is possible. Genes and their resulting products guarantee that the intricacy of cellular order (e.g., structures, defined reaction spaces (organelles) and reaction cascades) is preserved and transferred from generation to generation (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>). Supporters of the mutation and the aneuploidy hypotheses in particular emphasize the importance of the genome for life and focus their efforts on that single component in order to explain carcinogenesis.</p>
<p>In Figure <xref ref-type="fig" rid="F1">1</xref>, we illustrate in a simple scheme the importance of the complex interplay and reciprocal dependency of these three basic categories (matter, energy and information) and we invite the reader to investigate this fundamental interplay and to decide afterwards whether these categories are equally important to preserve life and order, or whether any one category can claim this right exclusively.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Self-preservation and reproduction are the fundamental characteristics of cells</bold>. To preserve all structures and functionalities, the cell must ingest matter (1<sup>&#x0002A;</sup>) to generate structural and functional, as well as specific energetic, molecules (2<sup>&#x0002A;</sup>). To meet these highly sophisticated properties, life has developed, through an evolutionary process, a molecular information system (3<sup>&#x0002A;</sup>) that guarantees structure, ordered processes, and a safe transfer of information from generation to generation. The scheme illustrates that matter, energy and information depend reciprocally on each other and, on this basis, it is clear that disturbance of any one of those properties must have consequences for the others. A cell is a thermodynamic, open system that is far away from equilibrium. For this reason, it displays a lower entropy state than the environment. Furthermore, we have to assume that entropy is not equally distributed, and that the complete entropy of a cell is in fact a sum of many different individual states. Disturbance of individual molecular mechanisms and structures has different consequences to the cell, but, if they are important enough and reach a state of irreversibility that cannot be repaired or compensated, then the cell enters a metastable state with all of the consequences that are explained in this text.</p></caption>
<graphic xlink:href="fcell-04-00121-g0001.tif"/>
</fig>
<p>If we accept that matter, energy and information are the basic categories that underpin and permit life, then a question emerges in the context of cancer: how can we assume that only the disturbance of information, through mutations, is exclusively able to initiate, and afterwards, drive, a process that is finally characterized by a chaotic progression of genomic, metabolic, morphological and other cell characteristics?</p>
<p>We suggest that in principle any perturbation of information, energy or matter is able to initiate undefined molecular changes within the ordered cell system that is described by the state function, entropy. This first event appears locally or generally, depending on the type and dimension of the affected basic category, and initiates and promotes a chaotic, self-organizing, and to some extent stochastic, process that can finally generate a cancer cell. In the following chapters, we will describe the impact of information, energy and matter on that process and discuss their importance in the initiation of increased entropy and disorder, and how they interact to promote cancer formation. But first of all, we would like to focus on that state function which describes the mechanisms responsible for cancer initiation and progression&#x02014;entropy.</p>
</sec>
<sec id="s3">
<title>Entropy and irreversible disorder</title>
<p>The second law of thermodynamics is the law that describes entropy. Entropy is a state function and a dimension for the increase in reaction probabilities, irreversibility, chaos and disorder in an ongoing system (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>; Davies et al., <xref ref-type="bibr" rid="B17">2013</xref>; Tarabichi et al., <xref ref-type="bibr" rid="B78">2013</xref>; Gomez, <xref ref-type="bibr" rid="B31">2014</xref>). The law says that in a closed system entropy either stays the same or gets bigger, and it therefore predicts that the universe tends toward maximum entropy (Wolfe, <xref ref-type="bibr" rid="B98">2015</xref>). For that reason, entropy defines a direction for all processes and reactions. A cell, however, is an enveloped but open thermodynamic system. That means that a cell has the opportunity to exchange both matter and energy with an outside system (the extracellular environment) and can release degradation products (positive entropy) such as CO<sub>2</sub>, H<sub>2</sub>O, heat and others (described here as thermodynamic waste). Because of that capability, the cell is able to maintain and increase cellular order within a progressively entropic environment. It therefore controls and provides optimal reaction conditions to generate structures and to preserve reaction cascades in circumscribed spaces. Principally, we can regard all of these intracellular mechanisms and structures as many single reaction states that become influenced by their intracellular local environment. For example, the structural order and the functionality of proteins are highly dependent upon conditions such as pH, electrolyte concentration and temperature (Wirth et al., <xref ref-type="bibr" rid="B97">2013</xref>; Uversky, <xref ref-type="bibr" rid="B87">2015</xref>). Under physiological conditions, the cell is able to control reaction probabilities in these different intracellular microenvironments and therefore it needs genomic information, nutrition (matter) and fuels (energy) (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>; Tarabichi et al., <xref ref-type="bibr" rid="B78">2013</xref>; Gomez, <xref ref-type="bibr" rid="B31">2014</xref>;). All of these processes are highly dynamic and the cell consumes a huge amount of energy to sustain all functionalities (Davies et al., <xref ref-type="bibr" rid="B17">2013</xref>).</p>
<p>However, based on the law of thermodynamics, we can deduce the following for highly complex, open thermodynamic systems such as cells: in reversible processes, entropy fluctuates in a defined dimension, whereas in irreversible ones, entropy has exceeded a point of no return that makes the reversal of the initiated changes impossible (see Figure <xref ref-type="fig" rid="F2">2</xref>). These fundamental perceptions are of central importance when we try to understand the origin and drivers of cancer (see below).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>A cell has the opportunity to sustain high order and self-preservation by utilizing energy and matter; and organization is achieved through the use of information molecules (see Figure 1)</bold>. For reasons provided in the preceding text, entropy can fluctuate reversibly within a specific range (area above 1<sup>&#x0002A;</sup>). In that context, we note especially that the described entropy fluctuation is a result of many individual entropic states representing reactions, mechanisms and structure. If one or more fluctuations exceeds a reaction-specific breaking point (1<sup>&#x0002A;</sup>), irreversibility sets in, and the future of the cell then depends upon its capability to stabilize itself in a metastable state (2<sup>&#x0002A;</sup>). This capability depends on adequate information (Figure <xref ref-type="fig" rid="F3">3</xref>), energy availability (Figure <xref ref-type="fig" rid="F4">4</xref>) and the supply of matter needed. If the degree of disorder is too strong, then cells pass the breaking point (3<sup>&#x0002A;</sup>) and die. In contrast, metastable cells persist in a process of permanent adaptation including the capability to reduce entropy locally (increase order) that can finally lead to cancer cell formation, as described in the main text. It is important to note that energy, matter and information are able individually to provoke the passage through the breaking point (1<sup>&#x0002A;</sup>); this is described in the main text, and in Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>.</p></caption>
<graphic xlink:href="fcell-04-00121-g0002.tif"/>
</fig>
<p>In physics, a stable state of a system is an equilibrium state (Wolfe, <xref ref-type="bibr" rid="B98">2015</xref>). When a process reaches equilibrium, reactivity stops because all driving forces are weakened. All systems follow this basic rule. However, because of its high degree of order, a cell is far away from equilibrium. This is possible because cells are open thermodynamic systems, which gives them the opportunity to permanently ingest matter and energy and to release waste, and thereby to preserve order (low entropy). Moreover, during evolution, the cell has gained a set of information molecules (e.g., DNA, RNA, and proteins) that guarantees self-preservation by self-organized processes and autonomous reproduction, and the transfer of that information from generation to generation (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>).</p>
<p>A consequence of the above is that the preservation of order (low entropy) in a cell depends upon these fundamental categories: information, energy and matter. If one of these categories is seriously disturbed, then cellular entropy increases (structurally or functionally), and an irreversible disorder may become established (Figure <xref ref-type="fig" rid="F2">2</xref>). What opportunities does a cell have in such a threatening situation? We postulate that at this stage a process is initiated that drives molecular mechanisms that lead to further increased intracellular entropy and that, in opposition to this process, competing cell reactions try to stabilize metabolism and cell integrity. The driving conflict behind these self-promoting mechanisms is that cells try to manage locally increased entropy through the interplay of locally available information, energy and matter. Because the second law of thermodynamics cannot allow for reversal of irreversible disorders, the cell is forced to establish a new order, i.e., to find a new stable state. A characteristic of this adaptive process is that regular cell processes reach points of progression where they come into conflict with irreversible disordered molecular mechanisms. The cell now has various options: first, if the disorder state is not &#x0201C;strong or relevant&#x0201D; enough, then it becomes compensated by the cell; second, if disorder is too strong, then the affected cell dies; or third, if the initiating event leads to a metastable state that is principally compatible with life, then it represents the base that maintains cell life, but at the same time it is the pre-condition for the progress of the molecular disorder that can finally lead to cancer cell formation (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<p>The principle of metastable cells is of central importance to our hypothesis. For that reason, it is important to explain what metastability means. As already mentioned, normal cells are highly ordered and preserve cell integrity and proper behavior within a functional tissue. They guarantee the safe transfer of cellular order from generation to generation. If that sophisticated and precisely orchestrated interplay becomes irreversibly disturbed (locally or generally), then the cell will never be the same because, in that moment, a functional or structural change becomes established within the cell that it can neither control nor repair. This change will constantly disrupt dependent mechanisms and, if disorder increases as a result, then the primarily ordered system becomes more and more chaotic. However, the cell loses efficiency and if that change provokes further disorder, then efficiency will decrease simultaneously. The decrease of efficiency must be associated with an increased release of heat and, in fact, tumor cells are characterized by an increased production and release of heat (Molnar et al., <xref ref-type="bibr" rid="B65">2011</xref>). The cell has the opportunity to compensate for this situation through various mechanisms (see below) and it is this interplay of persisting or increasing disorder, alongside cellular reactions that try to preserve life, which characterizes metastability.</p>
<p>In this context, several aspects are important. First, metastability is not based on predetermined events that lead to cancer; it is based on reaction probabilities outside of cellular control, and because of these probabilities, cell mechanisms and structure change to some extent stochastically until local or general equilibrium becomes established. The cell tries to compensate for this threat by activating various mechanisms including stress responses, energetic adaptation, apoptosis and epigenetic mechanisms and the cell changes continuously based on this sophisticated interplay. We believe that this is one of the reasons why pre-cancer cells and cancer cells display such significant metabolic changes (Cairns et al., <xref ref-type="bibr" rid="B14">2011</xref>; Keenan and Chi, <xref ref-type="bibr" rid="B46">2015</xref>) and an amazing morphological and genetic heterogeneity and behavior during progression (Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>).</p>
<p>The second important aspect is that the time period between the perturbation of the first category (information, energy or matter, which induces the process) and the involvement of the remaining categories is not clear and has to be evaluated. We assume that there will be large differences even within a single tumor or in pre-cancerous tissue (e.g., dysplasia, leukoplakia); and we speculate that there are cells characterized by the impact of a single or of only two affected category that may perhaps explain the <italic>restitutio ad integrum</italic> in some cases, or the reverse of malignancy after transplantation of non-cancerous mitochondria into cancer cells (see Introduction). In these transitions, epigenetics must play an important role to stabilize the metastable state and the progressive adaptation process. However, Bartesaghi and colleagues (Bartesaghi et al., <xref ref-type="bibr" rid="B6">2015</xref>) were able to show that inhibition of mitochondrial metabolism leads to p53 genetic inactivation; this gives unidentified insights into the relationships between mitochondria, genomic stability, and tumor-suppressive control mechanisms. These data are a good example of a causal link between the perturbation of one category in this case energy&#x02014;and the ensuing perturbation of a second one&#x02014;information&#x02014;that finally leads to cancer cell formation. Two questions in the context of our hypothesis are interesting. (A): Are there further mechanisms that become affected in that model because mitochondrial disturbance must initially be associated with a loss of energy that must affect other mechanisms and reactions too, and (B): What is the role of the environment (cell culture conditions) in that process? We suppose that artificial cell culture conditions also contribute to the results obtained.</p>
<p>Third, for cancer cell formation, the cell must preserve the capability to proliferate. If that ability becomes lost, then the cell is not able to adapt through an evolutionary process and cannot adjust the mechanisms it uses to preserve life. It is generally accepted that a normal cell has various different options to initiate and to preserve proliferation (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>), but in cancer cells the situation is different and the exact mechanisms why cancer cells show such a various and uncontrolled proliferation is not clear. For example, Hanahan and Weinberg (<xref ref-type="bibr" rid="B33">2011</xref>) discussed in their review that the induction of proliferation in cancer cannot be described simply by excessively elevated signaling by oncoproteins such as RAS, MYC or RAF. Such elevated signaling can, in fact, provoke a counteracting response from cells, specifically the induction of senescence and/or apoptosis. We suppose that oncogenes play an important role, but we believe that molecular and genetic deterministic descriptions are not sufficient to provide a comprehensive explanation of the induction of proliferation. As we discussed above, the local microenvironment is important for protein structure and function, too, and such modifications must have impact in the proliferation activation/inhibition cascade. Furthermore, the most processes and proteins depend on sufficient ATP, GTP, and other energy bearing molecules (energy) supply, and if the energy concentration becomes too low, then they lose activity including processes which are involved in proliferation mechanisms. Moreover, Szent-Gy&#x000F6;rgyi (<xref ref-type="bibr" rid="B76">1977</xref>) suggested many years ago that disorder produced by practically any influence has the ability to induce proliferation. He described, in a comprehensive model, that a small molecule such as methylglyoxal probably plays an important role in that process. However, the capability to proliferate undoubtedly underpins cell transformation and cancer development.</p>
<p>Furthermore, we suggest: cells that persist in a metastable state without proliferation have already been described as senescent cells (Childs et al., <xref ref-type="bibr" rid="B16">2015</xref>).</p>
</sec>
<sec id="s4">
<title>Information, entropy and disorder</title>
<disp-quote>
<p>&#x0201C;Information is the difference that makes a difference&#x0201D;</p>
<p><italic>Gregory Bateson</italic></p>
</disp-quote>
<p>Defining the basic principles of molecular information formation and the mechanisms for the generation of intrinsic information in molecules is highly complex and is based on fundamental physical laws (Umpleby, <xref ref-type="bibr" rid="B86">2007</xref>; Davies et al., <xref ref-type="bibr" rid="B17">2013</xref>; Tarabichi et al., <xref ref-type="bibr" rid="B78">2013</xref>; Wolfe, <xref ref-type="bibr" rid="B98">2015</xref>). However, in the context of this paper, information is defined as molecules (e.g., DNA, RNAs and proteins) which are transmitters and/or recipients of information with different information contents. Every molecule bears its own intrinsic information, which makes it unique, and any change of its composition or energy load will modify the information content, which could lead, for example, to changes of reactivity, molecule structure, molecular code or molecular disintegration. Based on their intrinsic information, myriads of molecules develop and establish morphological structures, activation or inhibition cascades, and all other cell functions and mechanisms by self-organizing processes (Karsenti, <xref ref-type="bibr" rid="B44">2008</xref>; Frieden and Gatenby, <xref ref-type="bibr" rid="B23">2011</xref>; Saetzler et al., <xref ref-type="bibr" rid="B72">2011</xref>). Because of its crucial importance for life, information, especially genes, stands at the focal point of biology and cancer research, and in recent decades some hypotheses have been formulated that indicate that specific changes in genes are the cause of cancer development. In fact, some cancer diseases, such as retinoblastoma and hereditary forms of breast cancer, are based on particular gene mutations (Lohmann and Gallie, <xref ref-type="bibr" rid="B53">2015</xref>; Kleibl and Kristensen, <xref ref-type="bibr" rid="B48">2016</xref>). However, at the same time, most scientists believe that information disturbances achieved during a lifetime are solely responsible for non-hereditary cancer diseases; and there are manifold ways of changing or disturbing cellular information. There is a general acceptance that specific mutations in cancer-associated genes are sufficient to induce processes that finally establish a somatic cancer cell (Hanahan and Weinberg, <xref ref-type="bibr" rid="B33">2011</xref>; Tomasetti and Vogelstein, <xref ref-type="bibr" rid="B81">2015</xref>). Others maintain that unspecific, large chromosomal rearrangements (aneuploidy) are the first step in initiating a progressive increase of disorder that can lead to cancer development (Boveri, <xref ref-type="bibr" rid="B11">1914</xref>; Storchova and Kuffer, <xref ref-type="bibr" rid="B75">2008</xref>; Duesberg et al., <xref ref-type="bibr" rid="B20">2011</xref>). In fact, both mechanisms belong to the same fundamental category&#x02014;information. Therefore, we suggest that any type of information disturbance can induce cancer by changing and influencing molecular mechanisms described by the state function, entropy (see Figure <xref ref-type="fig" rid="F3">3</xref>). However, the difference between the two hypotheses is that the accumulation of mutations in a cell is a slow step-by-step process, whereas chromosomal rearrangements can influence several 100 genes in one single event (Breivik, <xref ref-type="bibr" rid="B12">2005</xref>). A consequence of this difference for our hypothesis is that structural or functional information exceeds the breaking point of irreversibility in chromosomally imbalanced cells faster than in mutated ones (see Figure <xref ref-type="fig" rid="F3">3</xref>). Once that breaking point is passed, the cell is confronted with an irreversible disruption of formerly ordered structures and functions, and the future of the cell depends on the degree and type of the disorder state that is established (see above: metastability). The cell is now situated in the already-mentioned process of fatal interplay of the three fundamental categories (see above) and its future will depend on survivability with a &#x0201C;minimum information&#x0201D; content (Frieden and Gatenby, <xref ref-type="bibr" rid="B23">2011</xref>) and appropriate adaptations of the other two categories (matter and energy).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Initially, a cell possesses a high order and information level (low entropy)</bold>. Because of replication mistakes or for other intra- or extra-cellular reasons, mutations take place and entropy of information accumulates step-by-step (angled line). The consequence of a mutation depends on the importance of the affected (nucleotide) sequence and is symbolized in the graph by the different heights of the steps. In contrast, aneuploidy and CIN can affect several hundred genes in one event and for that reason, accumulation of entropy can increase in larger steps (rolling steps). However, once entropy of information exceeds a specific breaking point (1<sup>&#x0002A;</sup>), so many initially ordered mechanisms are irreversibly disturbed that the cell transitions into a metastable state (2<sup>&#x0002A;</sup>). In that state, the fate of the cell depends on its ability to achieve an acceptable stability in accordance with available energy and matter (see text). Many cells exceed the breaking point (3<sup>&#x0002A;</sup>) and die, but a few will be able to establish a metastable order based on a lower information content and may display all the characteristics of a cancer cell (see Figure <xref ref-type="fig" rid="F2">2</xref>). In that context, it is very surprising how many mutations and chromosomal aberrations cancer cells can tolerate and survive.</p></caption>
<graphic xlink:href="fcell-04-00121-g0003.tif"/>
</fig>
<p>There is one important aspect that we have to consider when we compare the progression of entropy development induced by information with that induced by energy disturbance, in an open cellular system. Information disturbance by mutations or aneuploidy is an accumulative process (see Figure <xref ref-type="fig" rid="F3">3</xref>) that, in the case of mutations, is limited by cellular repair mechanisms (Iyama and Wilson, <xref ref-type="bibr" rid="B40">2013</xref>). For that reason, entropy increases more or less constantly. On the other hand, a cell possesses, in part, the ability to compensate for an acute loss of energy, and this compensation results in a fluctuation of local energy concentration and intracellular entropy (see Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F4">4</xref>). This aspect has to be considered when assessing the interplay of these categories (information and energy) during the cancer-development process. In this context, the basis on which matter and environment affect cells differs from the basis on which information and energy exert their effects. Whereas, information and energy are both closely linked to the cell, matter and environment are defined by other cells too, and they depend upon external factors such as nutrition, perfusion, and morphology as well as the entropy released by surrounding cells, which is the subject of one of the next sections.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Under normal conditions a cell permanently ingests fuel and produces energy molecules such as ATP by respiration</bold>. For various reasons, the energy concentration under physiological conditions is not stable (see text) resulting in a reversible fluctuation of cellular entropy. As long as the energy concentration does not fall below a specific level, then all cellular mechanisms will run properly. But if the energy deficit exceeds that value (1<sup>&#x0002A;</sup>), then all cellular mechanisms will be affected, to a greater or lesser extent, and the initially ordered systems will transition into a metastable state (2<sup>&#x0002A;</sup>). The future of the cell now depends on the degree of the energy loss and the particular details of the systems affected. Based on these conditions, the cell has to achieve a new stable state, depending on the availability of matter and information. Because energy loss has an immediate influence on matter transportation and the preservation of information, it is difficult for the cell to establish a stable state (see Figure <xref ref-type="fig" rid="F2">2</xref>). Moreover, if the energy concentration is too low, then the cell dies (3<sup>&#x0002A;</sup>).</p></caption>
<graphic xlink:href="fcell-04-00121-g0004.tif"/>
</fig>
</sec>
<sec id="s5">
<title>Energy and entropy</title>
<p>The second law of thermodynamics states that within a thermodynamically closed system atoms and molecules tend toward a maximum of disorder, whereas energy gives systems the ability to organize themselves in dynamic patterns and structures. Cells as thermodynamically open, ordered and self-organizing systems highly depend on a sufficient energy and matter supply (Molnar et al., <xref ref-type="bibr" rid="B65">2011</xref>; Saetzler et al., <xref ref-type="bibr" rid="B72">2011</xref>; Davies et al., <xref ref-type="bibr" rid="B17">2013</xref>; Tarabichi et al., <xref ref-type="bibr" rid="B78">2013</xref>; Gomez, <xref ref-type="bibr" rid="B31">2014</xref>).</p>
<p>Otto Warburg and coworkers described for the first time that cancer cells metabolize a high amount of glucose to lactic acid, even under normoxic conditions. This phenomenon is well known as aerobic glycolysis or the &#x0201C;Warburg effect.&#x0201D; Yet Warburg&#x00027;s hypothesis includes much more than aerobic glycolysis. He also formulated that cancer results from irreversible mitochondrial (grana) dysfunction and an initial loss of energy induced by hypoxia, toxic agents, radiation or other reasons that later become compensated by glycolysis, or by other mechanisms such as glutaminolysis (Warburg, <xref ref-type="bibr" rid="B92">1924</xref>, <xref ref-type="bibr" rid="B93">1956</xref>; Keenan and Chi, <xref ref-type="bibr" rid="B46">2015</xref>). Moreover, he distinguished between two forms of energy loss: first, the already-mentioned demonstration that cancer cells show an irreversible loss of ATP production by respiration; and second, the &#x0201C;morphological inferiority&#x0201D; of glycolytically synthesized ATP (Warburg, <xref ref-type="bibr" rid="B92">1924</xref>, <xref ref-type="bibr" rid="B93">1956</xref>):</p>
<p>&#x0201C;&#x02026;One would think that it is immaterial to the cells whether they obtain their energy from respiration or from fermentation (glycolysis), since the energy of both reactions is transformed into energy of adenosine triphosphate&#x02026;This equation is certainly correct chemically and energetically, but it is incorrect morphologically, because, although respiration takes place for the most part in the structure of the grana (mitochondria), the fermentation enzymes are found for a greater part in the fluid protoplasma (cytosol). The adenosine triphosphate synthesized by respiration therefore involves more structure than the adenosine triphosphate synthesized by fermentation.&#x0201D; Otto Warburg (<xref ref-type="bibr" rid="B93">1956</xref>).</p>
<p>His suggestion that energy shows a variable distribution pattern is important and we have to take this aspect into account because, for example, several studies have suggested that enzymes can become differentially activated by energy gradients and that those gradients play an important role during mitosis (Bastiaens et al., <xref ref-type="bibr" rid="B7">2006</xref>; Karsenti, <xref ref-type="bibr" rid="B44">2008</xref>; Fuller, <xref ref-type="bibr" rid="B24">2010</xref>). Furthermore, it is well known that mitochondria are linked to the interphase microtubule network. This link is necessary because cells transfer mitochondria to areas where a higher energy concentration is needed. For example, Lawrence and Mandato were able to show that, after anaphase onset, mitochondria are recruited toward the site of cleavage furrow formation, where they remain enriched as the furrow ingresses until completion of cytokinesis (Lawrence and Mandato, <xref ref-type="bibr" rid="B51">2013</xref>). Aw was able to show that the mitochondrial distribution profiles in jejunal enterocytes changes from basal to apical while rats undergo fasting (Aw, <xref ref-type="bibr" rid="B3">2000</xref>). Furthermore, he describes ATP and oxygen gradients under hypoxic condition (Aw, <xref ref-type="bibr" rid="B3">2000</xref>; Aw and Jones, <xref ref-type="bibr" rid="B4">1985</xref>). We therefore assume that changes from energy gradients to amorphous distributed energy must have consequences for cancer cell formation too. For example, an optimal local concentration with tubulin alpha but without locally sufficient energy (GTP) during mitosis is deleterious because of the strong reciprocal dependency of both molecules in microtubule catastrophe and rescue mechanisms (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>; Gardner et al., <xref ref-type="bibr" rid="B27">2013</xref>; Brouhard, <xref ref-type="bibr" rid="B13">2015</xref>). We believe that even a temporary energy loss can provoke chromosomal imbalance and aneuploidy. Furthermore, we suggest that any relevant energy loss can have a major impact in provoking irreversible changes in other cellular functions, such as in DNA replication and repair, in the induction of apoptosis, and in others not yet characterized.</p>
<p>In his publication, Warburg (<xref ref-type="bibr" rid="B93">1956</xref>) discussed the relevance of initial energy loss (ATP) but, apart from his assumption that energy deprivation has three aspects (initial loss, energy compensation and morphological inferiority), and his remark that these changes provoke changes leading to cancer development, he did not explain which disturbed mechanisms support this process.</p>
<p>Cells have to synthesize their own usable energetic molecules (e.g., ATP, GTP) from ingested matter (e.g., glucose and oxygen) mainly by respiration, and the distribution of energy is influenced by several factors: (1) Morphological: for example, ATP creates concentration gradients around mitochondria and the diffusion behavior depends on surrounding structures (Aw, <xref ref-type="bibr" rid="B3">2000</xref>; Bastiaens et al., <xref ref-type="bibr" rid="B7">2006</xref>; Karsenti, <xref ref-type="bibr" rid="B44">2008</xref>; Fuller, <xref ref-type="bibr" rid="B24">2010</xref>). (2) Metabolic: because of increased metabolic requirements, for example, due to higher biosynthesis rates or to stress responses, cells accelerate their energy consumption, which impacts upon energy flow. (3) Biologically, because the energy demands have to be adapted during cell cycle and mitosis (Karsenti and Vernos, <xref ref-type="bibr" rid="B45">2001</xref>; Fuller, <xref ref-type="bibr" rid="B24">2010</xref>; Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>). Based on that assumption, we can postulate that energy availability under physiological conditions shows a high fluctuation rate, both locally and generally (see Figure <xref ref-type="fig" rid="F4">4</xref>). As long as the cell is able to provide sufficient energy, then the molecular mechanisms described by entropy fluctuate within a range that is compatible with physiological cell functions and structures. But if the energy content decreases even temporarily below a certain concentration level, then some molecular mechanisms shift from a reversibly fluctuating state to irreversibility. This shift is associated with an increase of entropy. Once the cells have entered this state, all energy-dependent systems must suffer under this energy deficiency, to a greater or lesser extent, with consequences for cell structure and functionality. The replication, repair and mitotic processes must, in particular, be significantly affected, which leads to an increased rate of mutations and aneuploidy, as has already been shown by Bartesaghi et al. (<xref ref-type="bibr" rid="B6">2015</xref>). However, because the cell has, in such situations, limited opportunities to immediately compensate for energy loss, it has limited opportunities to overcome this critical situation. Its destiny is decided by the degree of energy loss, the ability to ingest matter that is needed and the provision and availability of locally requested information. Reestablishing the original state is not possible, so the cell has to find a new order state through an evolutionary process by fluctuating on a higher entropy state level (see Figure <xref ref-type="fig" rid="F2">2</xref>). This state we define as a metastable state and as long as the cell maintains the capacity for self-preservation and reproduction then there is a risk that cancer cells are generated.</p>
</sec>
<sec id="s6">
<title>Matter, cell environment and entropy</title>
<p>A cell as an enveloped but open system is highly dependent upon an environment that provides all matter, within a defined range of concentrations, which is needed to sustain self-preservation and reproduction. To guarantee an optimal supply, the cell is surrounded by an extracellular matrix that contains all molecules [e.g., growth factors, nutrients, electrolytes, oxygen, protons (defined pH)] required and that provides conditions that are optimized to the appropriate functions of the cell. Based on its specific environment and genetic setting, any cell develops its own characteristics and adapts as one part of a functional multi-cell unit; bronchial tissue is an example (Alberts et al., <xref ref-type="bibr" rid="B1">2011</xref>). But what happens if this sophisticated adjustment is disturbed? What happen if the surrounding matter changes significantly or the cell becomes confronted with toxic agents? To answer these questions, two factors have to be considered, the type and the extent of the perturbing factors.</p>
<p>There are many ways of altering the cellular environment in a negative way, and in the past many experiments have been carried out that clearly show that cells exposed to a non-physiological environment such as toxic agents (Tsutsui et al., <xref ref-type="bibr" rid="B84">2000</xref>; Tayama et al., <xref ref-type="bibr" rid="B79">2008</xref>), inflammation (Kamp et al., <xref ref-type="bibr" rid="B42">2011</xref>; Marusawa and Jenkins, <xref ref-type="bibr" rid="B58">2014</xref>), low pH (Takeshi, <xref ref-type="bibr" rid="B77">1995</xref>; Gatenby and Gillies, <xref ref-type="bibr" rid="B29">2008</xref>), hypoxia (Fang et al., <xref ref-type="bibr" rid="B22">2008</xref>), infection (Castello et al., <xref ref-type="bibr" rid="B15">2010</xref>), irradiation (Nishisgori, <xref ref-type="bibr" rid="B67">2015</xref>), and others can induce significant genetic, metabolic, morphological and cell behavior changes and can initiate cancer development. But do all these factors exert their effect only by influencing genes that finally lead to cancer formation, as the supporters of the mutation theory predict? We claim that qualitative and quantitative changes in environmental matter can also negatively influence energy production, e.g., mitochondrial disturbance by heavy metals (Meyer et al., <xref ref-type="bibr" rid="B61">2013</xref>) or hypoxia (Seyfried, <xref ref-type="bibr" rid="B74">2015</xref>), and that these can have the same consequences as already described in the chapter above. It is clear that the close interaction and interdependency of the three fundamental categories of matter, energy and information are crucial for life and are equally responsible for the initiation and progression of cancer.</p>
</sec>
<sec sec-type="conclusions" id="s7">
<title>Conclusion</title>
<p>The hypothesis of cancer development suggested here proposes a change in the view of cancer development from a biologically mechanistic process, represented, for example, by genes that determine cell transformation through a linear chain of causal events, to a physical, biochemical, biological-dynamic and, to a certain extent, stochastic, process. To contend that (only) mutations in cancer-relevant genes are exclusively able to induce a complex disease such as cancer underplays the essential complexity of life and excludes the two other fundamental physical categories energy and matter&#x02014;as causes that are equally responsible for cancer initiation and progression.</p>
<p>Entropy is difficult to pin down, especially in the context of life and cellular systems, but we are convinced that the acceptance of that functional state as a dimension to describe, and to make statements about, the mechanisms responsible for cancer initiation and progression is of great importance.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>RH and CW contributed equally to this work and share first authorship.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>The research leading to this paper was supported by the ASKO Europastiftung Saarbr&#x000FC;cken and I.B. Frankfurt, Germany. Special thanks to Dr. Bruno von Lutz and Helmut Macher for critical language support.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Alberts</surname> <given-names>B.</given-names></name> <name><surname>Johnson</surname> <given-names>A.</given-names></name> <name><surname>Lewis</surname> <given-names>J.</given-names></name> <name><surname>Raff</surname> <given-names>M.</given-names></name> <name><surname>Roberts</surname> <given-names>K.</given-names></name> <name><surname>Walter</surname> <given-names>P.</given-names></name></person-group> (<year>2011</year>). <source>Molecular Biology of the Cell, 5th Edn.</source> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Garland Science</publisher-name>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Attallaha</surname> <given-names>A. M.</given-names></name> <name><surname>Tablla</surname> <given-names>A. A.</given-names></name> <name><surname>Salem</surname> <given-names>S. F.</given-names></name> <name><surname>El-Sadany</surname> <given-names>M.</given-names></name> <name><surname>Ibrahim</surname> <given-names>T. A.</given-names></name> <name><surname>Osmanc</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>DNA ploidy of liver biopsies from patients with liver cirrhosis and hepatocellular carcinoma: a flow cytometric analysis</article-title>. <source>Cancer Lett.</source> <volume>142</volume>, <fpage>65</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3835(99)00165-2</pub-id><pub-id pub-id-type="pmid">10424782</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aw</surname> <given-names>T. Y.</given-names></name></person-group> (<year>2000</year>). <article-title>Intracellular compartmentation of organelles and gradients of low molecular weight species</article-title>. <source>Int. Rev. Cytol.</source> <volume>192</volume>, <fpage>223</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7696(08)60528-8</pub-id><pub-id pub-id-type="pmid">10553281</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aw</surname> <given-names>T. Y.</given-names></name> <name><surname>Jones</surname> <given-names>D. P.</given-names></name></person-group> (<year>1985</year>). <article-title>ATP concentration gradients in cytosol of liver cells during hypoxia</article-title>. <source>Am. J. Physiol.</source> <volume>249</volume>, <fpage>C385</fpage>&#x02013;<lpage>C392</lpage>. <pub-id pub-id-type="pmid">2998197</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>A cancer theory kerfuffle can lead to new lines of research</article-title>. <source>J. Natl. Cancer Inst.</source> <volume>107</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/dju405</pub-id><pub-id pub-id-type="pmid">25766401</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartesaghi</surname> <given-names>S.</given-names></name> <name><surname>Graziano</surname> <given-names>V.</given-names></name> <name><surname>Galavotti</surname> <given-names>S.</given-names></name> <name><surname>Henriquez</surname> <given-names>N. V.</given-names></name> <name><surname>Betts</surname> <given-names>J.</given-names></name> <name><surname>Saxena</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>112</volume>, <fpage>1059</fpage>&#x02013;<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1413165112</pub-id><pub-id pub-id-type="pmid">25713129</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastiaens</surname> <given-names>P.</given-names></name> <name><surname>Caudron</surname> <given-names>M.</given-names></name> <name><surname>Niethammer</surname> <given-names>P.</given-names></name> <name><surname>Karsenti</surname> <given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Gradients in the self-organization of the mitotic spindle</article-title>. <source>Trends Cell. Biol.</source> <volume>16</volume>, <fpage>125</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2006.01.005</pub-id><pub-id pub-id-type="pmid">16478663</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benevolenskaya</surname> <given-names>E. V.</given-names></name> <name><surname>Frolov</surname> <given-names>M. V.</given-names></name></person-group> (<year>2015</year>). <article-title>Emerging links between E2F control and mitochondrial function</article-title>. <source>Cancer Res.</source> <volume>75</volume>, <fpage>619</fpage>&#x02013;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-2173</pub-id><pub-id pub-id-type="pmid">25634216</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bensaad</surname> <given-names>K.</given-names></name> <name><surname>Tsuruta</surname> <given-names>A.</given-names></name> <name><surname>Selak</surname> <given-names>M. A.</given-names></name> <name><surname>Vidal</surname> <given-names>M. N.</given-names></name> <name><surname>Nakano</surname> <given-names>K.</given-names></name> <name><surname>Bartrons</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>TIGAR, a p53-inducible regulator of glycolysis and apoptosis</article-title>. <source>Cell</source> <volume>126</volume>, <fpage>107</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.05.036</pub-id><pub-id pub-id-type="pmid">16839880</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bohm</surname> <given-names>N.</given-names></name> <name><surname>Sandritter</surname> <given-names>W.</given-names></name></person-group> (<year>1975</year>). <article-title>DNA in human tumors: a cytophotometric study, Current topics in pathology</article-title>. <source>Ergebnisse der Pathol.</source> <volume>60</volume>, <fpage>151</fpage>&#x02013;<lpage>219</lpage>. <pub-id pub-id-type="pmid">1104277</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Boveri</surname> <given-names>T.</given-names></name></person-group> (<year>1914</year>). <source>Zur Frage der Entstehung Maligner Tumoren</source>. <publisher-loc>Jena</publisher-loc>: <publisher-name>Fischer Verlag</publisher-name>.</citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breivik</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The evolutionary origin of genetic instability in cancer development</article-title>. <source>Semin. Cancer. Biol.</source> <volume>15</volume>, <fpage>51</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2004.09.008</pub-id><pub-id pub-id-type="pmid">15613288</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brouhard</surname> <given-names>G. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Dynamic instability 30 years later: complexities in microtubule growth and catastrophe</article-title>. <source>Mol. Biol. Cell.</source> <volume>26</volume>, <fpage>1207</fpage>&#x02013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E13-10-0594</pub-id><pub-id pub-id-type="pmid">25823928</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cairns</surname> <given-names>R. A.</given-names></name> <name><surname>Harris</surname> <given-names>I. S.</given-names></name> <name><surname>Mak</surname> <given-names>T. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of cancer cell metabolism</article-title>. <source>Nat. Rev. Cancer</source> <volume>11</volume>, <fpage>85</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2981</pub-id><pub-id pub-id-type="pmid">21258394</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castello</surname> <given-names>G.</given-names></name> <name><surname>Scala</surname> <given-names>S.</given-names></name> <name><surname>Palmieri</surname> <given-names>G.</given-names></name> <name><surname>Curley</surname> <given-names>S. A.</given-names></name></person-group> (<year>2010</year>). <article-title>HCV-related hepatocellular carcinoma: from chronic inflammation to cancer</article-title>. <source>Clin. Immunol.</source> <volume>134</volume>, <fpage>237</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2009.10.007</pub-id><pub-id pub-id-type="pmid">19910258</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname> <given-names>B. G.</given-names></name> <name><surname>Durik</surname> <given-names>M.</given-names></name> <name><surname>Baker</surname> <given-names>D. J.</given-names></name> <name><surname>van Deursen</surname> <given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Cellular senescence in aging and age related diseases: from mechanisms to therapy</article-title>. <source>Nat. Med.</source> <volume>21</volume>, <fpage>1424</fpage>&#x02013;<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4000</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>P.</given-names></name> <name><surname>Rieper</surname> <given-names>E.</given-names></name> <name><surname>Tuszynski</surname> <given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Self-organization and entropy reducing in a living cell</article-title>. <source>Biosystems</source> <volume>111</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.biosystems.2012.10.005</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duesberg</surname> <given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Does aneuploidy or mutation start cancer?</article-title> <source>Science</source> <volume>307</volume>, <fpage>41</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1126/science.307.5706.41d</pub-id><pub-id pub-id-type="pmid">15637254</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duesberg</surname> <given-names>P. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Does aneuploidy destabilize karyotypes automatically?</article-title> <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>111</volume>:<fpage>E974</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.1401413111</pub-id><pub-id pub-id-type="pmid">24569866</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duesberg</surname> <given-names>P.</given-names></name> <name><surname>Mandrioli</surname> <given-names>D.</given-names></name> <name><surname>McCormack</surname> <given-names>A.</given-names></name> <name><surname>Nicholson</surname> <given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Is carcinogenesis a form of speciation?</article-title> <source>Cell Cycle</source> <volume>10</volume>, <fpage>2100</fpage>&#x02013;<lpage>2114</lpage>. <pub-id pub-id-type="doi">10.4161/cc.10.13.16352</pub-id><pub-id pub-id-type="pmid">21666415</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ermis</surname> <given-names>A.</given-names></name> <name><surname>Oberringer</surname> <given-names>M.</given-names></name> <name><surname>Wirbel</surname> <given-names>R.</given-names></name> <name><surname>Koschnick</surname> <given-names>M.</given-names></name> <name><surname>Mutschler</surname> <given-names>W.</given-names></name> <name><surname>Hanselmann</surname> <given-names>R. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Tetraploidization is a physiological enhancer of wound healing</article-title>. <source>Eur. Surg. Res.</source> <volume>30</volume>, <fpage>385</fpage>&#x02013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1159/000008603</pub-id><pub-id pub-id-type="pmid">9838230</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname> <given-names>J. S.</given-names></name> <name><surname>Gillies</surname> <given-names>R. D.</given-names></name> <name><surname>Gatenby</surname> <given-names>R. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression</article-title>. <source>Semin. Cancer. Biol.</source> <volume>18</volume>, <fpage>330</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2008.03.011</pub-id><pub-id pub-id-type="pmid">18455429</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frieden</surname> <given-names>B. R.</given-names></name> <name><surname>Gatenby</surname> <given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Information dynamics in living systems: prokaryotes, eukaryotes, and cancer</article-title>. <source>PLoS ONE</source> <volume>6</volume>:<fpage>e22085</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022085</pub-id><pub-id pub-id-type="pmid">21818295</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname> <given-names>B. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Self-organization of intracellular gradients during mitosis</article-title>. <source>Cell. Div.</source> <volume>5</volume>, <fpage>1</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1186/1747-1028-5-5</pub-id><pub-id pub-id-type="pmid">20181052</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname> <given-names>S. M.</given-names></name> <name><surname>Ivett</surname> <given-names>J. L.</given-names></name></person-group> (<year>1986</year>). <article-title>Chemically induced aneuploidy in mammalian cells in culture</article-title>, <source>Mutat. Res.</source> <volume>167</volume>, <fpage>89</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1110(86)90011-4</pub-id><pub-id pub-id-type="pmid">3941674</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganem</surname> <given-names>N. J.</given-names></name> <name><surname>Storchova</surname> <given-names>Z.</given-names></name> <name><surname>Pellman</surname> <given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Tetraploidy, aneuploidy and cancer</article-title>. <source>Curr. Opin. Genet. Dev.</source> <volume>17</volume>, <fpage>157</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2007.02.011</pub-id><pub-id pub-id-type="pmid">17324569</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname> <given-names>M. K.</given-names></name> <name><surname>Zanic</surname> <given-names>M.</given-names></name> <name><surname>Howard</surname> <given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Microtubule catastrophe and rescue</article-title>. <source>Curr. Opin. Cell. Biol.</source> <volume>25</volume>, <fpage>14</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2012.09.006</pub-id><pub-id pub-id-type="pmid">23092753</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gatenby</surname> <given-names>R. A.</given-names></name> <name><surname>Frieden</surname> <given-names>B. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Growth of stable order in eukaryotes from environment energy</article-title>. <source>Bull. Math. Biol.</source> <volume>75</volume>, <fpage>589</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1007/s11538-013-9821-x</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gatenby</surname> <given-names>R. A.</given-names></name> <name><surname>Gillies</surname> <given-names>R. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Hypoxia and metabolism - Opinion - A microenvironmental model of carcinogenesis</article-title>. <source>Nat. Rev. Cancer</source> <volume>8</volume>, <fpage>56</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2255</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gillies</surname> <given-names>R. J.</given-names></name> <name><surname>Gatenby</surname> <given-names>R. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Metabolism and its sequelae in cancer evolution and therapy</article-title>. <source>Cancer J.</source> <volume>21</volume>, <fpage>88</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1097/PPO.0000000000000102</pub-id><pub-id pub-id-type="pmid">25815848</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname> <given-names>A. V.</given-names></name></person-group> (<year>2014</year>). <source>The Thermodynamics of the Living Organisms: Entropy Production in the Cell</source>. arXiv:1410.8820v1 (physics.bio-ph).</citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grosovsky</surname> <given-names>A. J.</given-names></name> <name><surname>Parks</surname> <given-names>K. K.</given-names></name> <name><surname>Giver</surname> <given-names>C. R.</given-names></name> <name><surname>Nelson</surname> <given-names>S. L.</given-names></name></person-group> (<year>1996</year>). <article-title>Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability</article-title>. <source>Mol. Cell. Biol.</source> <volume>16</volume>, <fpage>6252</fpage>&#x02013;<lpage>6262</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.16.11.6252</pub-id><pub-id pub-id-type="pmid">8887655</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname> <given-names>D.</given-names></name> <name><surname>Weinberg</surname> <given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source> <volume>144</volume>, <fpage>646</fpage>&#x02013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanselmann</surname> <given-names>R. G.</given-names></name> <name><surname>Oberringer</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Polyploidization: a Janus-faced mechanism</article-title>. <source>Med. Hypotheses</source> <volume>56</volume>, <fpage>58</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1054/mehy.2000.1111</pub-id><pub-id pub-id-type="pmid">11133256</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansemann</surname> <given-names>D.</given-names></name></person-group> (<year>1892</year>). <article-title>&#x000DC;ber die Anaplasie der Geschwulstzellen und die asymmetrische Mitose</article-title>. <source>Arch. Pathol. Anat. Physiol. Klin. Med.</source> <volume>129</volume>, <fpage>436</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1007/BF01938307</pub-id></citation>
</ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasle</surname> <given-names>H.</given-names></name> <name><surname>Clemmensen</surname> <given-names>I. H.</given-names></name> <name><surname>Mikkelsen</surname> <given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Risks of leukaemia and solid tumours in individuals with Down&#x00027;s syndrome</article-title>. <source>Lancet</source> <volume>355</volume>, <fpage>165</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(99)05264-2</pub-id><pub-id pub-id-type="pmid">10675114</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname> <given-names>L. A.</given-names></name> <name><surname>Prada</surname> <given-names>D.</given-names></name> <name><surname>Andonegui</surname> <given-names>M. A.</given-names></name> <name><surname>Duenas-Gonz&#x000E1;lez</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>The epigenetic origin of aneuploidy</article-title>. <source>Curr. Genomics</source> <volume>9</volume>, <fpage>43</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.2174/138920208783884883</pub-id><pub-id pub-id-type="pmid">19424483</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname> <given-names>A. J.</given-names></name> <name><surname>Cleveland</surname> <given-names>D. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis</article-title>. <source>Nat. Rev. Mol. Cell. Bio.</source> <volume>10</volume>, <fpage>478</fpage>&#x02013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2718</pub-id><pub-id pub-id-type="pmid">19546858</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname> <given-names>A. J.</given-names></name> <name><surname>Cleveland</surname> <given-names>D. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Losing balance: the origin and impact of aneuploidy in cancer</article-title>. <source>Embo. Rep.</source> <volume>13</volume>, <fpage>501</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2012.55</pub-id><pub-id pub-id-type="pmid">22565320</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyama</surname> <given-names>T.</given-names></name> <name><surname>Wilson</surname> <given-names>D. M.</given-names></name></person-group> (<year>2013</year>). <article-title>DNA repair mechanisms in dividing and non-dividing cells</article-title>. <source>DNA Rep.</source> <volume>12</volume>, <fpage>620</fpage>&#x02013;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1016/j.dnarep.2013.04.015</pub-id><pub-id pub-id-type="pmid">23684800</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaipparettu</surname> <given-names>B. A.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Park</surname> <given-names>J. H.</given-names></name> <name><surname>Lee</surname> <given-names>T. L.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Yotnda</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways</article-title>. <source>PLoS ONE</source>. <volume>8</volume>:<fpage>e61747</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061747</pub-id><pub-id pub-id-type="pmid">23671572</pub-id></citation>
</ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamp</surname> <given-names>D. W.</given-names></name> <name><surname>Shacter</surname> <given-names>E.</given-names></name> <name><surname>Weitzman</surname> <given-names>S. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Chronic inflammation and cancer: the role of the mitochondria</article-title>. <source>Oncology</source> <volume>25</volume>, <fpage>400</fpage>&#x02013;<lpage>413</lpage>. <pub-id pub-id-type="pmid">21710835</pub-id></citation>
</ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamp</surname> <given-names>W. M.</given-names></name> <name><surname>Wang</surname> <given-names>P. Y.</given-names></name> <name><surname>Hwang</surname> <given-names>P. M.</given-names></name></person-group> (<year>2016</year>). <article-title>TP53 mutation, mitochondria and cancer</article-title>. <source>Curr. Opin. Genet. Dev.</source> <volume>38</volume>, <fpage>16</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2016.02.007</pub-id><pub-id pub-id-type="pmid">27003724</pub-id></citation>
</ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karsenti</surname> <given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>Self-organization in cell biology: a brief history</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>9</volume>, <fpage>255</fpage>&#x02013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2357</pub-id><pub-id pub-id-type="pmid">18292780</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karsenti</surname> <given-names>E.</given-names></name> <name><surname>Vernos</surname> <given-names>I.</given-names></name></person-group> (<year>2001</year>). <article-title>Cell cycle - The mitotic spindle: a self-made machine</article-title>. <source>Science</source> <volume>294</volume>, <fpage>543</fpage>&#x02013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1126/science.1063488</pub-id><pub-id pub-id-type="pmid">11641489</pub-id></citation>
</ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keenan</surname> <given-names>M. M.</given-names></name> <name><surname>Chi</surname> <given-names>J. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Alternative fuels for cancer cells</article-title>. <source>Cancer J.</source> <volume>21</volume>, <fpage>49</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1097/PPO.0000000000000104</pub-id><pub-id pub-id-type="pmid">25815843</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirsch-Volders</surname> <given-names>M.</given-names></name> <name><surname>Tallon</surname> <given-names>I.</given-names></name> <name><surname>Tanzarella</surname> <given-names>C.</given-names></name> <name><surname>Sgura</surname> <given-names>A.</given-names></name> <name><surname>Hermine</surname> <given-names>T.</given-names></name> <name><surname>Parry</surname> <given-names>E. M.</given-names></name> <etal/></person-group>. (<year>1996</year>). <article-title>Mitotic non-disjunction as a mechanism for <italic>in vitro</italic> aneuploidy induction by X-rays in primary human cells</article-title>. <source>Mutagenesis</source> <volume>11</volume>, <fpage>307</fpage>&#x02013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1093/mutage/11.4.307</pub-id><pub-id pub-id-type="pmid">8671754</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleibl</surname> <given-names>Z.</given-names></name> <name><surname>Kristensen</surname> <given-names>V. N.</given-names></name></person-group> (<year>2016</year>). <article-title>Women at high risk of breast cancer: molecular characteristics, clinical presentation and management</article-title>. <source>Breast</source> <volume>15</volume>, <fpage>136</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.breast.2016.05.006</pub-id><pub-id pub-id-type="pmid">27318168</pub-id></citation>
</ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>J.</given-names></name> <name><surname>Shin</surname> <given-names>S. M.</given-names></name> <name><surname>Oh</surname> <given-names>Y. M.</given-names></name> <name><surname>Lee</surname> <given-names>Y. S.</given-names></name> <name><surname>Ryoo</surname> <given-names>Z. Y.</given-names></name> <name><surname>Lee</surname> <given-names>Y. H.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice</article-title>. <source>Oncogene</source> <volume>23</volume>, <fpage>1950</fpage>&#x02013;<lpage>1953</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1207356</pub-id><pub-id pub-id-type="pmid">14691448</pub-id></citation>
</ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondoh</surname> <given-names>M.</given-names></name> <name><surname>Ohga</surname> <given-names>N.</given-names></name> <name><surname>Akiyama</surname> <given-names>K.</given-names></name> <name><surname>Hida</surname> <given-names>Y.</given-names></name> <name><surname>Maishi</surname> <given-names>N.</given-names></name> <name><surname>Towfik</surname> <given-names>A. M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e80349</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0080349</pub-id><pub-id pub-id-type="pmid">24260373</pub-id></citation>
</ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>E. J.</given-names></name> <name><surname>Mandato</surname> <given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondria localize to the cleavage furrow in mammalian cytokinesis</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e72886</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0072886</pub-id><pub-id pub-id-type="pmid">23991162</pub-id></citation>
</ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lengauer</surname> <given-names>C.</given-names></name> <name><surname>Kinzler</surname> <given-names>K. W.</given-names></name> <name><surname>Vogelstein</surname> <given-names>B.</given-names></name></person-group> (<year>1998</year>). <article-title>Genetic instability in human cancer</article-title>. <source>Nature</source> <volume>396</volume>, <fpage>643</fpage>&#x02013;<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1038/25292</pub-id></citation>
</ref>
<ref id="B53">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Lohmann</surname> <given-names>D. R.</given-names></name> <name><surname>Gallie</surname> <given-names>B. L.</given-names></name></person-group> (<year>2015</year>). <source>Retinoblastoma. GeneReviews (Internet)</source>. <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Seattle</publisher-name>.</citation>
</ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lothsch&#x000FC;tz</surname> <given-names>D.</given-names></name> <name><surname>Jennewein</surname> <given-names>M.</given-names></name> <name><surname>Pahl</surname> <given-names>S.</given-names></name> <name><surname>Lausberg</surname> <given-names>H. F.</given-names></name> <name><surname>Eichler</surname> <given-names>A.</given-names></name> <name><surname>Mutschler</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Polyploidization and centrosome hyperamplification in inflammatory bronchi</article-title>. <source>Inflamm. Res.</source> <volume>51</volume>, <fpage>416</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1007/PL00000323</pub-id><pub-id pub-id-type="pmid">12234059</pub-id></citation>
</ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname> <given-names>S. C.</given-names></name> <name><surname>Witt</surname> <given-names>H.</given-names></name> <name><surname>Piro</surname> <given-names>R. M.</given-names></name> <name><surname>Gu</surname> <given-names>L.</given-names></name> <name><surname>Zuyderduyn</surname> <given-names>S.</given-names></name> <name><surname>St&#x000FC;tz</surname> <given-names>A. M.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Epigenomic alterations define lethal CIMP-positive ependymomas of infancy</article-title>. <source>Nature</source> <volume>506</volume>, <fpage>445</fpage>&#x02013;<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1038/nature13108</pub-id><pub-id pub-id-type="pmid">24553142</pub-id></citation>
</ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mally</surname> <given-names>A.</given-names></name> <name><surname>Chipman</surname> <given-names>J. K.</given-names></name></person-group> (<year>2002</year>). <article-title>Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat</article-title>. <source>Toxicology</source> <volume>180</volume>, <fpage>233</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/S0300-483X(02)00393-1</pub-id><pub-id pub-id-type="pmid">12393293</pub-id></citation>
</ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martincorena</surname> <given-names>I.</given-names></name> <name><surname>Roshan</surname> <given-names>A.</given-names></name> <name><surname>Gerstung</surname> <given-names>M.</given-names></name> <name><surname>Ellis</surname> <given-names>P.</given-names></name> <name><surname>Van Loo</surname> <given-names>P.</given-names></name> <name><surname>McLaren</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>High burden and pervasive positive selection of somatic mutations in normal human skin</article-title>. <source>Science</source> <volume>348</volume>, <fpage>880</fpage>&#x02013;<lpage>886</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaa6806</pub-id><pub-id pub-id-type="pmid">25999502</pub-id></citation>
</ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marusawa</surname> <given-names>H.</given-names></name> <name><surname>Jenkins</surname> <given-names>B. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Inflammation and gastrointestinal cancer: an overview</article-title>. <source>Cancer Lett.</source> <volume>345</volume>, <fpage>153</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2013.08.025</pub-id><pub-id pub-id-type="pmid">23981579</pub-id></citation>
</ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matoba</surname> <given-names>S.</given-names></name> <name><surname>Kang</surname> <given-names>J. G.</given-names></name> <name><surname>Patino</surname> <given-names>W. D.</given-names></name> <name><surname>Wragg</surname> <given-names>A.</given-names></name> <name><surname>Boehm</surname> <given-names>M.</given-names></name> <name><surname>Gavrilova</surname> <given-names>O.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>p53 regulates mitochondrial respiration</article-title>. <source>Science</source> <volume>312</volume>, <fpage>1650</fpage>&#x02013;<lpage>1653</lpage>. <pub-id pub-id-type="doi">10.1126/science.1126863</pub-id><pub-id pub-id-type="pmid">16728594</pub-id></citation>
</ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattiuzzo</surname> <given-names>M.</given-names></name> <name><surname>Fiore</surname> <given-names>M.</given-names></name> <name><surname>Ricordy</surname> <given-names>R.</given-names></name> <name><surname>Degrassi</surname> <given-names>F.</given-names></name></person-group> (<year>2006</year>). <article-title>Aneuploidy-inducing capacity of two widely used pesticides</article-title>, <source>Carcinogenesis</source> <volume>27</volume>, <fpage>2511</fpage>&#x02013;<lpage>2518</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgl102</pub-id><pub-id pub-id-type="pmid">16777991</pub-id></citation>
</ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>J. N.</given-names></name> <name><surname>Leung</surname> <given-names>M. C. K.</given-names></name> <name><surname>Rooney</surname> <given-names>J. P.</given-names></name> <name><surname>Sendoel</surname> <given-names>A.</given-names></name> <name><surname>Hengartner</surname> <given-names>M. O.</given-names></name> <name><surname>Kisby</surname> <given-names>G. E.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Mitochondria as a target of environmental toxicants</article-title>. <source>Toxicol. Sci.</source> <volume>134</volume>, <fpage>1</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kft102</pub-id><pub-id pub-id-type="pmid">23629515</pub-id></citation>
</ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michiels</surname> <given-names>C.</given-names></name> <name><surname>Tellier</surname> <given-names>C.</given-names></name> <name><surname>Feron</surname> <given-names>O.</given-names></name></person-group> (<year>2016</year>). <article-title>Cycling hypoxia: a key feature of the tumor environment</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1866</volume>, <fpage>76</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbcan.2016.06.004</pub-id><pub-id pub-id-type="pmid">27343712</pub-id></citation>
</ref>
<ref id="B63">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>J. G.</given-names></name></person-group> (<year>1978</year>). <source>Living Systems</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>.</citation>
</ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moggia</surname> <given-names>M.</given-names></name> <name><surname>Colombo</surname> <given-names>I.</given-names></name> <name><surname>Peverelli</surname> <given-names>L.</given-names></name> <name><surname>Villa</surname> <given-names>L.</given-names></name> <name><surname>Xhani</surname> <given-names>R.</given-names></name> <name><surname>Testolin</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Mitochondrial disease heterogeneity: a prognostic challenge</article-title>. <source>Acta Myol.</source> <volume>33</volume>, <fpage>86</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="pmid">25709378</pub-id></citation>
</ref>
<ref id="B65">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Molnar</surname> <given-names>J.</given-names></name> <name><surname>Varga</surname> <given-names>Z. G.</given-names></name> <name><surname>Thornton-Benko</surname> <given-names>E.</given-names></name> <name><surname>Thornton</surname> <given-names>B. S.</given-names></name></person-group> (<year>2011</year>). <article-title>The second law of thermodynamics and host-tumor relationship: concepts and opportunities</article-title>, in <source>Application of Thermodynamics to Biological and Materials Science</source>, ed <person-group person-group-type="editor"><name><surname>Mizutani</surname></name></person-group> (<publisher-loc>Rijeka</publisher-loc>: <publisher-name>InTech</publisher-name>), <fpage>203</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.5772/12973</pub-id></citation>
</ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nigg</surname> <given-names>E. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Centrosome aberrations: cause or consequence of cancer progression?</article-title> <source>Nat. Rev. Cancer</source> <volume>2</volume>, <fpage>815</fpage>&#x02013;<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1038/nrc924</pub-id><pub-id pub-id-type="pmid">26432751</pub-id></citation>
</ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishisgori</surname> <given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Current concept of photocarcinogenesis</article-title>. <source>Photochem. Photobiol.</source> <volume>14</volume>, <fpage>1713</fpage>&#x02013;<lpage>1721</lpage>. <pub-id pub-id-type="doi">10.1039/C5PP00185D</pub-id><pub-id pub-id-type="pmid">26177397</pub-id></citation>
</ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oberringer</surname> <given-names>M.</given-names></name> <name><surname>Lothsch&#x000FC;tz</surname> <given-names>D.</given-names></name> <name><surname>Jennewein</surname> <given-names>M.</given-names></name> <name><surname>Koschnick</surname> <given-names>M.</given-names></name> <name><surname>Mutschler</surname> <given-names>W.</given-names></name> <name><surname>Hanselmann</surname> <given-names>R. G.</given-names></name></person-group> (<year>1999</year>). <article-title>Centrosome multiplication accompanies a transient clustering of polyploid cells during tissue repair</article-title>, <source>Mol. Cell Biol. Res. Commun.</source> <volume>2</volume>, <fpage>190</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1006/mcbr.1999.0172</pub-id><pub-id pub-id-type="pmid">10662596</pub-id></citation>
</ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rademakers</surname> <given-names>S. E.</given-names></name> <name><surname>Span</surname> <given-names>P. N.</given-names></name> <name><surname>Kaanders</surname> <given-names>J. H.</given-names></name> <name><surname>Sweep</surname> <given-names>F. C.</given-names></name> <name><surname>van der Kogel</surname> <given-names>A. J.</given-names></name> <name><surname>Bussink</surname> <given-names>J.</given-names></name></person-group>. (<year>2008</year>). <article-title>Molecular aspects of tumour hypoxia</article-title>. <source>Mol. Oncol.</source> <volume>2</volume>, <fpage>41</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="pmid">19383328</pub-id></citation>
</ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehen</surname> <given-names>S. K.</given-names></name> <name><surname>Yung</surname> <given-names>Y. C.</given-names></name> <name><surname>McCreight</surname> <given-names>M. P.</given-names></name> <name><surname>Kaushal</surname> <given-names>D.</given-names></name> <name><surname>Yang</surname> <given-names>A. H.</given-names></name> <name><surname>Almeida</surname> <given-names>B. S. V.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Constitutional aneuploidy in the normal human brain</article-title>. <source>J. Neurosci.</source> <volume>25</volume>, <fpage>2176</fpage>&#x02013;<lpage>2180</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4560-04.2005</pub-id><pub-id pub-id-type="pmid">15745943</pub-id></citation>
</ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname> <given-names>B. J.</given-names></name> <name><surname>Levine</surname> <given-names>D. S.</given-names></name> <name><surname>Longton</surname> <given-names>G.</given-names></name> <name><surname>Blount</surname> <given-names>P. L.</given-names></name> <name><surname>Rabinovitch</surname> <given-names>P. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Predictors of progression to cancer in barrett&#x00027;s esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets</article-title>. <source>Am. J. Gastroenterol.</source> <volume>95</volume>, <fpage>1669</fpage>&#x02013;<lpage>1676</lpage>. <pub-id pub-id-type="doi">10.1111/j.1572-0241.2000.02196.x</pub-id><pub-id pub-id-type="pmid">10925966</pub-id></citation>
</ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saetzler</surname> <given-names>K.</given-names></name> <name><surname>Sonnenschein</surname> <given-names>C.</given-names></name> <name><surname>Soto</surname> <given-names>A. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Systems biology beyond networks: generating order from disorder through self-organization</article-title>. <source>Semin. Cancer Biol.</source> <volume>21</volume>, <fpage>165</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2011.04.004</pub-id><pub-id pub-id-type="pmid">21569848</pub-id></citation>
</ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandritter</surname> <given-names>W.</given-names></name></person-group> (<year>1965</year>). <article-title>DNA content of tumours. Cytophotometric measurements</article-title>. <source>Eur. J. Cancer</source> <volume>1</volume>. <fpage>303</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2964(65)90065-4</pub-id><pub-id pub-id-type="pmid">5896134</pub-id></citation>
</ref>
<ref id="B74">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seyfried</surname> <given-names>T. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Cancer as a mitochondrial metabolic disease</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>3</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3389/fcell.2015.00043</pub-id><pub-id pub-id-type="pmid">26217661</pub-id></citation>
</ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Storchova</surname> <given-names>Z.</given-names></name> <name><surname>Kuffer</surname> <given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>The consequences of tetraploidy and aneuploidy</article-title>. <source>J. Cell. Sci.</source> <volume>121</volume>, <fpage>3859</fpage>&#x02013;<lpage>3866</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.039537</pub-id><pub-id pub-id-type="pmid">19020304</pub-id></citation>
</ref>
<ref id="B76">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szent-Gy&#x000F6;rgyi</surname> <given-names>A.</given-names></name></person-group> (<year>1977</year>). <article-title>The living state and cancer</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>74</volume>, <fpage>2844</fpage>&#x02013;<lpage>2847</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.74.7.2844</pub-id><pub-id pub-id-type="pmid">268635</pub-id></citation>
</ref>
<ref id="B77">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeshi</surname> <given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Low ph leads to sister-chromatid exchange and chromosomal aberrations, and its clastogenicity is S-dependent</article-title>. <source>Mutat. Res.</source> <volume>334</volume>, <fpage>301</fpage>&#x02013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1161(95)90067-5</pub-id><pub-id pub-id-type="pmid">7753094</pub-id></citation>
</ref>
<ref id="B78">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarabichi</surname> <given-names>M.</given-names></name> <name><surname>Antoniou</surname> <given-names>A.</given-names></name> <name><surname>Saiselet</surname> <given-names>M.</given-names></name> <name><surname>Pita</surname> <given-names>J. M.</given-names></name> <name><surname>Andry</surname> <given-names>G.</given-names></name> <name><surname>Dumont</surname> <given-names>J. E.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>System biology of cancer: entropy, disorder, and selection driven evolution to independence, invasion and &#x0201C;swarm intelligence&#x0201D;</article-title>. <source>Cancer Metastasis Rev.</source> <volume>32</volume>, <fpage>403</fpage>&#x02013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1007/s10555-013-9431-y</pub-id><pub-id pub-id-type="pmid">23615877</pub-id></citation>
</ref>
<ref id="B79">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tayama</surname> <given-names>S.</given-names></name> <name><surname>Nakagawa</surname> <given-names>Y.</given-names></name> <name><surname>Tayama</surname> <given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells</article-title>. <source>Mutat. Res.</source> <volume>649</volume>, <fpage>114</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrgentox.2007.08.006</pub-id><pub-id pub-id-type="pmid">17913570</pub-id></citation>
</ref>
<ref id="B80">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname> <given-names>S. L.</given-names></name> <name><surname>Bakhoum</surname> <given-names>S. F.</given-names></name> <name><surname>Compton</surname> <given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Mechanisms of chromosomal instability</article-title>. <source>Curr. Biol.</source> <volume>20</volume>, <fpage>R285</fpage>&#x02013;<lpage>R295</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2010.01.034</pub-id><pub-id pub-id-type="pmid">20334839</pub-id></citation>
</ref>
<ref id="B81">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomasetti</surname> <given-names>C.</given-names></name> <name><surname>Vogelstein</surname> <given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Cancer etiology. Variations in cancer risk among tissue can be explained by number of stem cell divisions</article-title>. <source>Science</source> <volume>347</volume>, <fpage>78</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1126/science.1260825</pub-id></citation>
</ref>
<ref id="B82">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname> <given-names>E. M.</given-names></name> <name><surname>Williams</surname> <given-names>B. R.</given-names></name> <name><surname>Amon</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Aneuploidy: cells losing their balance</article-title>. <source>Genetics</source> <volume>179</volume>, <fpage>737</fpage>&#x02013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.108.090878</pub-id><pub-id pub-id-type="pmid">18558649</pub-id></citation>
</ref>
<ref id="B83">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsutsui</surname> <given-names>T.</given-names></name> <name><surname>Barrett</surname> <given-names>J. C.</given-names></name></person-group> (<year>1997</year>). <article-title>Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals</article-title>. <source>Environ. Health Persp.</source> <volume>105</volume>, <fpage>619</fpage>&#x02013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.97105s3619</pub-id><pub-id pub-id-type="pmid">9168005</pub-id></citation>
</ref>
<ref id="B84">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsutsui</surname> <given-names>T.</given-names></name> <name><surname>Tamura</surname> <given-names>Y.</given-names></name> <name><surname>Suzuki</surname> <given-names>A.</given-names></name> <name><surname>Hirose</surname> <given-names>Y.</given-names></name> <name><surname>Kobayashi</surname> <given-names>M.</given-names></name> <name><surname>Nishimura</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Mammalian cell transformation and aneuploidy induced by five bisphenols</article-title>. <source>Int. J. Cancer.</source> <volume>86</volume>, <fpage>151</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(20000415)86:2&#x0003C;151::AID-IJC1&#x0003E;3.0.CO;2-0</pub-id><pub-id pub-id-type="pmid">10738239</pub-id></citation>
</ref>
<ref id="B85">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueyama</surname> <given-names>H.</given-names></name> <name><surname>Horibe</surname> <given-names>T.</given-names></name> <name><surname>Hinotsu</surname> <given-names>S.</given-names></name> <name><surname>Tanaka</surname> <given-names>T.</given-names></name> <name><surname>Inoue</surname> <given-names>T.</given-names></name> <name><surname>Urushihara</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions</article-title>. <source>J. Cell. Mol. Med.</source> <volume>16</volume>, <fpage>72</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01303.x</pub-id><pub-id pub-id-type="pmid">21418515</pub-id></citation>
</ref>
<ref id="B86">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umpleby</surname> <given-names>S. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Physical relationships among matter, energy and information</article-title>. <source>Syst. Res. Behav. Sci.</source> <volume>24</volume>, <fpage>369</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1002/sres.761</pub-id></citation>
</ref>
<ref id="B87">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uversky</surname> <given-names>V. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Functional roles of transiently and intrinsically disordered regions within proteins</article-title>. <source>FEBS J.</source> <volume>282</volume>, <fpage>1182</fpage>&#x02013;<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1111/febs.13202</pub-id><pub-id pub-id-type="pmid">25631540</pub-id></citation>
</ref>
<ref id="B88">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Zyl</surname> <given-names>A. W.</given-names></name> <name><surname>van Heerden</surname> <given-names>M. B.</given-names></name> <name><surname>Langenegger</surname> <given-names>E.</given-names></name> <name><surname>van Heerden</surname> <given-names>W. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Correlation between dysplasia and ploidy status in oral leukoplakia</article-title>. <source>Head Neck Pathol.</source> <volume>6</volume>, <fpage>322</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1007/s12105-012-0352-9</pub-id><pub-id pub-id-type="pmid">22430773</pub-id></citation>
</ref>
<ref id="B89">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Versteeg</surname> <given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Cancer: tumours outside the mutation box</article-title>. <source>Nature.</source> <volume>506</volume>, <fpage>438</fpage>&#x02013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1038/nature13061</pub-id><pub-id pub-id-type="pmid">24553138</pub-id></citation>
</ref>
<ref id="B90">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Virchow</surname> <given-names>R.</given-names></name></person-group> (<year>1858</year>). <source>Die Cellularpathologie in ihrer Begr&#x000FC;ndung auf physiologische und pathologische Gewebelehre</source>. <publisher-loc>Berlin</publisher-loc>. <publisher-name>von August Hirschwald Verlag</publisher-name>.</citation>
</ref>
<ref id="B91">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitale</surname> <given-names>I.</given-names></name> <name><surname>Senovilla</surname> <given-names>L.</given-names></name> <name><surname>Jema&#x000E1;</surname> <given-names>M.</given-names></name> <name><surname>Michaud</surname> <given-names>M.</given-names></name> <name><surname>Galluzzi</surname> <given-names>L.</given-names></name> <name><surname>Kepp</surname> <given-names>O.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos</article-title>. <source>EMBO J.</source> <volume>29</volume>, <fpage>1272</fpage>&#x02013;<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2010.11</pub-id><pub-id pub-id-type="pmid">20186124</pub-id></citation>
</ref>
<ref id="B92">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname> <given-names>O.</given-names></name></person-group> (<year>1924</year>). <article-title>&#x000DC;ber den Stoffwechsel der Carcinomzelle</article-title>. <source>Die Naturwissenschaften</source> <volume>50</volume>, <fpage>1131</fpage>&#x02013;<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1007/BF01504608</pub-id></citation>
</ref>
<ref id="B93">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname> <given-names>O.</given-names></name></person-group> (<year>1956</year>). <article-title>On the origin of cancer cells</article-title>. <source>Science</source> <volume>123</volume>, <fpage>309</fpage>&#x02013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1126/science.123.3191.309</pub-id><pub-id pub-id-type="pmid">13298683</pub-id></citation>
</ref>
<ref id="B94">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname> <given-names>B. A. A.</given-names></name> <name><surname>Cleveland</surname> <given-names>D. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Aneuploidy: instigator and inhibitor of tumorigenesis</article-title>. <source>Cancer Res.</source> <volume>67</volume>, <fpage>10103</fpage>&#x02013;<lpage>10105</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2266</pub-id><pub-id pub-id-type="pmid">17974949</pub-id></citation>
</ref>
<ref id="B95">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname> <given-names>B. A. A.</given-names></name> <name><surname>Silk</surname> <given-names>A. D.</given-names></name> <name><surname>Montagna</surname> <given-names>C.</given-names></name> <name><surname>Verdier-Pinard</surname> <given-names>P.</given-names></name> <name><surname>Cleveland</surname> <given-names>D. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Aneuploidy acts both oncogenically and as a tumor suppressor</article-title>. <source>Cancer Cell.</source> <volume>11</volume>, <fpage>25</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2006.12.003</pub-id><pub-id pub-id-type="pmid">17189716</pub-id></citation>
</ref>
<ref id="B97">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wirth</surname> <given-names>A. J.</given-names></name> <name><surname>Platkov</surname> <given-names>M.</given-names></name> <name><surname>Gruebele</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Temporal variation of a protein folding energy landscape in the cell</article-title>. <source>J. Am. Chem. Soc.</source> <volume>135</volume>, <fpage>19215</fpage>&#x02013;<lpage>19221</lpage>. <pub-id pub-id-type="doi">10.1021/ja4087165</pub-id><pub-id pub-id-type="pmid">24304346</pub-id></citation>
</ref>
<ref id="B98">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Wolfe</surname> <given-names>J.</given-names></name></person-group> (<year>2015</year>). <source>Cellular Thermodynamics: the Molecular and Macroscopic Views</source>. <publisher-loc>Chichester</publisher-loc>: <publisher-name>John Wiley &#x00026; Sons, Ltd</publisher-name>.</citation>
</ref>
<ref id="B99">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname> <given-names>K. W.</given-names></name> <name><surname>Desai</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>The wages of CIN</article-title>. <source>J. Cell Biol.</source> <volume>180</volume>, <fpage>661</fpage>&#x02013;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200801030</pub-id><pub-id pub-id-type="pmid">18283117</pub-id></citation>
</ref>
</ref-list>
</back>
</article>